FLASH: Jury deems J&J's DePuy ASR XL hip implant defective in design, orders $8.3M in damages

March 8, 2013 by Arezu Sarvestani

Johnson & Johnson defends its DePuy subsidiary's ASR XL hip devices after a California jury finds that the metal-on-metal implants were defectively designed, awarding plaintiff Loren Kransky $8.3 million in compensatory damages.

hip implant x-ray

A California jury ruled against Johnson & Johnson (NYSE:JNJ) and its DePuy subsidiary in finding that the company's ASR XL metal-on-metal hip implant was defectively designed.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.